Results 241 to 250 of about 134,167 (281)

Physical activity and the risk of cataract and age-related macular degeneration: a systematic review and meta-analysis of cohort studies. [PDF]

BMC Ophthalmol
Aune D, Jayedi A, Kazemi A, Soltani S, Rezaei F, Leitzmann MF.   +5 more
europepmc   +1 more source

Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration. [PDF]

PLoS One
Iby J, Coulibaly L, Hollaus M, Yeghiazaryan L, Schmidt-Erfurth U, Bühl W, Sacu S.   +6 more
europepmc   +1 more source

LONG-TERM EFFICACY AND SAFETY OF PHOTOBIOMODULATION IN DRY AGE-RELATED MACULAR DEGENERATION (LIGHTSITE III: 24-MONTH ANALYSIS). [PDF]

Retina
Jaffe GJ, Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, Lad E, Rosen RB, Do DV, Schneiderman T, Ho AC, Munk MR, Tedford SE, Croissant CL, Rückert R, Lavin PT, Tedford CE.   +16 more
europepmc   +1 more source

Gene Therapy for Wet Age-Related Macular Degeneration. [PDF]

Bioengineering (Basel)
Barthelemy N, Sridhar J, Sengillo JD.
europepmc   +1 more source

Long-Term Follow-Up of Faricimab Intravitreal Injections in Naïve Neovascular Age-Related Macular Degeneration.

Ophthalmic Res
Belloni Baroni L, Toto L, Formenti F, Passamonti M, Quarta A, Ruggeri ML, Aloia R, Di Nicola M, Mastropasqua R.   +8 more
europepmc   +1 more source

Age-related macular degeneration [PDF]

Nature Reviews Disease Primers, 2021
Age-related macular degeneration (AMD) is a leading cause of blindness. The main risk factor is advancing age, with the severity of vision loss ranging from mild to severe. There is a 25% risk of early AMD and 8% risk of late AMD in patients over the age of 75, with the number of cases expected to increase because of the aging population.
Monika Fleckenstein, Tiarnán D L Keenan, Usha Chakravarthy   +2 more
exaly   +13 more sources

Some of the next articles are maybe not open access.

Related searches:

Age-related macular degeneration

Lancet, The, 2023
Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. Age-related macular degeneration affects individuals older than 55 years and threatens high-acuity central vision required for important tasks such as reading, driving, and recognising faces.
Robyn H Guymer, Thomas G Campbell
exaly   +3 more sources

Age-related macular degeneration [PDF]

Lancet, The, 2008
Age-related macular degeneration is the leading cause of blindness in elderly populations of European descent. The most consistent risk factors associated with this ocular condition are increasing age and cigarette smoking. Genetic investigations have shown that complement factor H, a regulator of the alternative complement pathway, and LOC387715/HtrA1
Chi-Chao Chan, Emily Y Chew
exaly   +5 more sources